Genetics of Osteoporosis

• Melton LJ : How many women have osteoporosis now?J. Bone Miner. Res.10, 175–177(1995).
   PubMed Web of Science ®Google Scholar
• Bonewald LF , JohnsonML: Osteocytes, mechanosensing and Wnt signaling.Bone42, 606–615(2008).
   PubMed Web of Science ®Google Scholar
• van Oers RF , RuimermanR, TanckE, HilbersPA, HuiskesR: A unified theory for osteonal and hemi-osteonal remodeling.Bone42, 250–259(2008).
   PubMed Web of Science ®Google Scholar
• Hofbauer LC , HeufelderAE: Role of receptor activator of nuclear factor-κB ligand and osteoprotegerin in bone cell biology.J. Mol. Med.79, 243–253(2001).
   PubMed Web of Science ®Google Scholar
• Riancho JA , MundyGR: The role of cytokines and growth factors as mediators of the effects of systemic hormones at the bone local level.Crit. Rev. Eukaryot. Gene Expr.5, 193–217(1995).
   PubMed Web of Science ®Google Scholar
• Zaidi M : Skeletal remodeling in health and disease.Nat. Med.13, 791–801(2007).
   PubMed Web of Science ®Google Scholar
• Baron R , RawadiG: Wnt signaling and the regulation of bone mass.Curr. Osteoporos. Rep.5, 73–80(2007).
   PubMedGoogle Scholar
• Johnson ML , KamelMA: The Wnt signaling pathway and bone metabolism.Curr. Opin. Rheumatol.19, 376–382(2007).
   PubMed Web of Science ®Google Scholar
• Riggs BL , MeltonLJ, RobbRAet al.: A population-based assessment of rates of bone loss at multiple skeletal sites: evidence for substantial trabecular bone loss in young adult women and men. J. Bone Miner. Res.23, 205–214(2008).
   PubMed Web of Science ®Google Scholar
• Ralston SH : Genetic control of susceptibility to osteoporosis.J. Clin. Endocrinol. Metab.87, 2460–2466(2002).
   PubMed Web of Science ®Google Scholar
• Peacock M , TurnerCH, EconsMJ, Foroud T: Genetics of osteoporosis. Endocr. Rev.23, 303–326(2002).
   PubMed Web of Science ®Google Scholar
• Nguyen TV , HowardGM, KellyPJ, Eisman JA: Bone mass, lean mass, and fat mass: same genes or same environments? Am. J. Epidemiol.147, 3–16(1998).
   PubMed Web of Science ®Google Scholar
• Wang X , KammererCM, WheelerVW, PatrickAL, BunkerCH, ZmudaJM: Genetic and environmental determinants of volumetric and areal BMD in multi-generational families of African ancestry: the Tobago Family Health Study.J. Bone Miner. Res.22, 527–536(2007).
   PubMed Web of Science ®Google Scholar
• Duncan EL , CardonLR, SinsheimerJS, WassJA, BrownMA: Site and gender specificity of inheritance of bone mineral density.J. Bone Miner. Res.18, 1531–1538(2003).
   PubMedGoogle Scholar
• Lenchik L , HsuFC, RegisterTCet al.: Heritability of spinal trabecular volumetric bone mineral density measured by QCT in the Diabetes Heart Study. Calcif. Tissue Int.75, 305–312(2004).
   PubMed Web of Science ®Google Scholar
• Brown LB , StreetenEA, ShapiroJRet al.: Genetic and environmental influences on bone mineral density in pre- and post-menopausal women. Osteoporos. Int.16, 1849–1856(2005).
   PubMed Web of Science ®Google Scholar
• Makovey J , NguyenTV, NaganathanV, Wark JD, Sambrook PN: Genetic effects on bone loss in peri- and postmenopausal women: a longitudinal twin study. J. Bone Miner. Res.22, 1773–1780(2007).
   PubMed Web of Science ®Google Scholar
• Havill LM , MahaneyMC, BinkleyL, Specker BL: Effects of genes, sex, age, and activity on BMC, bone size, and areal and volumetric BMD. J. Bone Miner. Res.22, 737–746(2007).
   PubMed Web of Science ®Google Scholar
• Chen Y , GuoYF, LeiSF, WangYB,Deng HW: Genetic and environmental correlations between bone mineral density and bone size in Caucasians. Hum. Biol.79, 15–24(2007).
   PubMed Web of Science ®Google Scholar
• Cummings SR , NevittMC, BrownerWSet al.: Risk factors for hip fracture in white women. N. Engl. J. Med.332, 767–773(1995).
   PubMed Web of Science ®Google Scholar
• Kanis JA , JohanssonH, OdenAet al.: A family history of fracture and fracture risk: a meta-analysis. Bone35, 1029–1037(2004).
   PubMed Web of Science ®Google Scholar
• Ralston SH , de Crombrugghe B: Genetic regulation of bone mass and susceptibility to osteoporosis. Genes Dev.20, 2492–2506(2006).
   PubMed Web of Science ®Google Scholar
• Michaelsson K , MelhusH, FermH, AhlbomA, PedersenNL: Genetic liability to fractures in the elderly.Arch. Intern. Med.165, 1825–1830(2005).
   PubMed Web of Science ®Google Scholar
• Liu YZ , LiuYJ, ReckerRR, DengHW: Molecular studies of identification of genes for osteoporosis: the 2002 update.J. Endocrinol.177, 147–196(2003).
   PubMed Web of Science ®Google Scholar
• Ioannidis JP , NgMY, ShamPCet al.: Meta-analysis of genome-wide scans provides evidence for sex- and site-specific regulation of bone mass. J. Bone Miner. Res.22, 173–183(2007).
   PubMed Web of Science ®Google Scholar
• Liu YJ , ShenH, XiaoPet al.: Molecular genetic studies of gene identification for osteoporosis: a 2004 update. J. Bone Miner. Res.21, 1511–1535(2006).
   PubMed Web of Science ®Google Scholar
• Morrison NA , QiJC, TokitaAet al.: Prediction of bone density from vitamin D receptor alleles. Nature367, 284–287(1994).
   PubMed Web of Science ®Google Scholar
• Fang Y , RivadeneiraF, van Meurs JB, Pols HA, Ioannidis JP, Uitterlinden AG: Vitamin D receptor gene BsmI and TaqI polymorphisms and fracture risk: a meta-analysis. Bone39, 938–945(2006).
   PubMed Web of Science ®Google Scholar
• Fang Y , van Meurs JB, Bergink AP et al.: Cdx-2 polymorphism in the promoter region of the human vitamin D receptor gene determines susceptibility to fracture in the elderly. J. Bone Miner. Res.18(9), 1632–1641(2003).
   PubMed Web of Science ®Google Scholar
• Uitterlinden AG , FangY, van Meurs JB, Pols HA, van Leeuwen JP: Genetics and biology of vitamin D receptor polymorphisms. Gene338(2), 143–156(2004).
   PubMed Web of Science ®Google Scholar
• Uitterlinden AG , RalstonSH, BrandiMLet al.: The association between common vitamin D receptor gene variations and osteoporosis: a participant-level meta-analysis. Ann. Int. Med.145, 255–264(2006).
   PubMed Web of Science ®Google Scholar
• Herynk MH , FuquaSAW: Estrogen receptor mutations in human disease.Endocr. Rev.25, 869–898(2004).
   PubMed Web of Science ®Google Scholar
• Turner RT , RiggsBL, SpelsbergTC: Skeletal effects of estrogen.Endocr. Rev.15, 275–300(1994).
   PubMed Web of Science ®Google Scholar
• Khosla S , MeltonLJ, RiggsBL: Estrogen and the male skeleton.J. Clin. Endocrinol. Metab.87, 1443–1450(2002).
   PubMed Web of Science ®Google Scholar
• Riggs BL , KhoslaS, MeltonIII LJ: Sex steroids and the construction and conservation of adult skeleton. Endocr. Rev.23, 279–302(2002).
   PubMed Web of Science ®Google Scholar
• Syed FS , KhoslaS: Mechanisms of sex steroid effects on bone.Biochem. Biophys. Res. Commun.328, 688–696(2005).
   PubMed Web of Science ®Google Scholar
• Deroo BJ , KorachKS: Estrogen receptors and human disease.J. Clin. Invest.116, 561–570(2006).
   PubMed Web of Science ®Google Scholar
• Cranney A , GuyattG, GriffithL, WellsG, TugwellP, RosenC: Summary of meta-analyses of therapies for postmenopausal osteoporosis.Endocr. Rev.23, 570–578(2002).
   PubMed Web of Science ®Google Scholar
• Torgerson DJ , Bell-SyerSEM: Hormone replacement therapy and prevention of nonvertebral fractures. A meta-analysis of randomized trials.JAMA285, 2891–2897(2001).
   PubMed Web of Science ®Google Scholar
• Gennari L , MerlottiD, MartiniGet al.: Longitudinal association between sex hormone levels, bone loss, and bone turnover in elderly men. J. Clin. Endocrinol. Metab.88, 5327–5333(2003).
   PubMed Web of Science ®Google Scholar
• Khosla S , MeltonLJ, III, Atkinson EJ, O‘Fallon WM, Klee GG, Riggs BL: Relationship of serum sex steroid levels and bone turnover markers with bone mineral density in men and women: a key role for bioavailable estrogen. J. Clin. Endocrinol. Metab.83, 2266–2274(1998).
   PubMed Web of Science ®Google Scholar
• Kobayashi S , InoueS, HosoiT, OuchiY, ShirakiM, OrimoH: Association of bone mineral density with polymorphism of the estrogen receptor gene.J. Bone Miner. Res.11, 306–311(1996).
   PubMed Web of Science ®Google Scholar
• Ioannidis JPA , RalstonSH, BennettSTet al.: Differential genetics effects of ESR1 gene polymorphisms on osteoporosis outcomes. JAMA292, 2105–2114(2004).
   PubMed Web of Science ®Google Scholar
• Ioannidis JPA , StavrouI, TrikalinosTAet al.: Association of polymorphisms of the estrogen receptor α gene with bone mineral density and fracture risk in women: a meta-analysis. J. Bone Miner. Res.17, 2048–2060(2002).
   PubMed Web of Science ®Google Scholar
• Sano M , InoueS, HosoiTet al.: Association of estrogen receptor dinucleotide repeat polymorphism with osteoporosis. Biochem. Biophys. Res. Commun.217, 378–383(1995).
   PubMed Web of Science ®Google Scholar
• Langdahl BL , LokkeE, CarstensM, StenkjaerLL, EriksenEF: A TA repeat polymorphism in the estrogen receptor gene is associated with osteoporotic fractures but polymorphisms in the first intron are not.J. Bone Miner. Res.15, 2222–2230(2000).
   PubMed Web of Science ®Google Scholar
• Riancho JA , ZarrabeitiaMT, ValeroC, SanudoC, MijaresV, Gonzalez-MaciasJ: A gene-to-gene interaction between aromatase and estrogen receptors influences bone mineral density.Eur. J. Endocrinol.155, 53–59(2006).
   PubMed Web of Science ®Google Scholar
• Gennari L , MerlottiD, De Paola V et al.: Estrogen receptor gene polymorphisms and the genetics of osteoporosis: a HuGE review. Am. J. Epidemiol.161, 307–320(2005).
   PubMed Web of Science ®Google Scholar
• Van Meurs JBJ , SchuitSCE, WeelAEAMet al.: Association of 5´ estrogen receptor α gene polymorphisms with bone mineral density, vertebral bone area and fracture risk. Human Molecular Genetics12, 1745–1754(2003).
   PubMed Web of Science ®Google Scholar
• Scariano JK , SimplicioSG, MontoyaGD, GarryPJ, BaumgartnerRN: Estrogen receptor β dinucleotide (CA) repeat polymorphism is significantly associated with bone mineral density in postmenopausal women.Calcif. Tissue Int.74, 501–508(2004).
   PubMed Web of Science ®Google Scholar
• Lau HHL , HoAYY, LukKDK, KungAWC: Estrogen receptor β gene polymorphisms are associated with higher bone mineral density in premenopausal, but not postmenopausal southern chinese women.Bone31, 276–281(2002).
   PubMed Web of Science ®Google Scholar
• Ichikawa S , KollerDL, PeacockMet al.: Polymorphisms in the estrogen receptor β (ESR2) gene are associated with bone mineral density in Caucasian men and women. J. Clin. Endocrinol. Metab.90, 5921–5927(2005).
   PubMed Web of Science ®Google Scholar
• Shearman AM , KarasikD, GruenthalKMet al.: Estrogen receptor β polymorphisms are associated with bone mass in women and men: The Framingham study. J. Bone Miner. Res.19, 773–781(2004).
   PubMed Web of Science ®Google Scholar
• Greendale GA , ChuJ, FerrellR, Randolph JF, Jr., Johnston JM, Sowers MR: The association of bone mineral density with estrogen receptor gene polymorphisms. Am. J. Med.119(9 Suppl. 1), S79–S86 (2006).
   PubMed Web of Science ®Google Scholar
• Rivadeneira F , van Meurs JB, Kant J et al.: Estrogen receptor β (ESR2) polymorphisms in interaction with estrogen receptor α (ESR1) and insulin-like growth factor I (IGF1) variants influence the risk of fracture in postmenopausal women. J. Bone Miner. Res.21, 1443–1456(2006).
   PubMed Web of Science ®Google Scholar
• Gruber CJ , TschugguelW, SchneebergerC, HuberJC: Mechanisms of disease: production and actions of estrogens.N. Engl. J. Med.346, 340–352(2002).
   PubMed Web of Science ®Google Scholar
• McCloskey E : Effects of third-generation aromatase inhibitors on bone.Eur. J. Cancer42, 1044–1051(2006).
   PubMed Web of Science ®Google Scholar
• Lester J , ColemanR: Bone loss and the aromatase inhibitors.Br. J. Cancer93(Suppl. 1), S16–S22 (2005).
   PubMed Web of Science ®Google Scholar
• Riancho JA : Polymorphisms in the CYP19 gene that influence bone mineral density.Pharmacogenomics8, 339–352(2007).
   PubMed Web of Science ®Google Scholar
• Zarrabeitia MT , HernandezJL, ValeroCet al.: A common polymorphism in the 5´-untranslated region of the aromatase gene influences bone mass and fracture risk. Eur. J. Endocrinol.150, 699–704(2004).
   PubMed Web of Science ®Google Scholar
• Riancho JA , ZarrabeitiaMT, ValeroCet al.: Aromatase gene and osteoporosis: relationship of ten polymorphic loci with bone mineral density. Bone36, 917–925(2005).
   PubMed Web of Science ®Google Scholar
• Enjuanes A , Garcia-GiraltN, SuperviaAet al.: A new SNP in a negative regulatory region of the CYP19A1 gene is associated with lumbar spine BMD in postmenopausal women. Bone38, 738–743(2006).
   PubMed Web of Science ®Google Scholar
• Masi L , BecheriniL, GennariLet al.: Polymorphism of the aromatase gene in postmenopausal italian women: distribution and correlation with bone mass and fracture risk. J. Clin. Endocrinol. Metab.86, 2263–2269(2001).
   PubMed Web of Science ®Google Scholar
• Riancho JA , ValeroC, NaranjoA, Morales DJ, Sanudo C, Zarrabeitia MT: Identification of an aromatase haplotype that is associated with gene expression and postmenopausal osteoporosis. J. Clin. Endocrinol. Metab.92, 660–665(2007).
   PubMed Web of Science ®Google Scholar
• Valero C , Perez-CastrillonJL, Zarrabeitia MT et al.: Association of aromatase and estrogen receptor gene polymorphisms with hip fractures. Osteoporos. Int.19, 787–792(2008).
   Google Scholar
• Salmen T , HeikkinenAM, MahonenAet al.: Relation of androgen receptor gene polymorphism to bone mineral density and fracture risk in early postmenopausal women during a 5-year randomized hormone replacement therapy trial. J. Bone Miner. Res.18, 319–324(2003).
   PubMed Web of Science ®Google Scholar
• Tofteng CL , KindmarkA, BrandstromHet al.: Polymorphisms in the CYP19 and AR genes – relation to bone mass and longitudinal bone changes in postmenopausal women with or without hormone replacement therapy: The Danish Osteoporosis Prevention Study. Calcif. Tissue Int.74, 25–34(2004).
   PubMed Web of Science ®Google Scholar
• Moron FJ , MendozaN, VazquezFet al.: Multilocus analysis of estrogen-related genes in Spanish postmenopausal women suggests an interactive role of ESR1, ESR2 and NRIP1 genes in the pathogenesis of osteoporosis. Bone39, 213–221(2006).
   PubMed Web of Science ®Google Scholar
• Mendoza N , MoronFJ, VazquezFet al.: Weighting the effect of CYP19A gene in bone mineral density of postmenopausal women. Bone38, 951–953(2006).
   Google Scholar
• Valero C , ZarrabeitiaMT, HernandezJL, ZarrabeitiaMT, González-MacíasJ, RianchoJA: Bone mass in young adults: relationship with gender, weight, and genetic factors.J. Intern. Med.258, 554–562(2005).
   PubMed Web of Science ®Google Scholar
• Labrie F , BelangerA, CusanL, GómezJL, CandasB: Marked decline in serum concentrations of adrenal C19 sex steroid precursors and conjugated androgen metabolites during aging.J. Clin. Endocrinol. Metab.82, 2396–2402(1997).
   PubMed Web of Science ®Google Scholar
• Johnson ML , HarnishK, NusseR, Van Hul W: LRP5 and Wnt signaling: a union made for bone. J. Bone Miner. Res.19, 1749–1757(2004).
   PubMed Web of Science ®Google Scholar
• Gordon MD , NusseR: Wnt signaling: multiple pathways, multiple receptors, and multiple transcription factors.J. Biol. Chem.281, 22429–22433(2006).
   PubMed Web of Science ®Google Scholar
• Li X , ZhangY, KangHet al.: Sclerostin binds to LRP5/6 and antagonizes canonical Wnt signaling. J. Biol. Chem.280, 19883–19887(2005).
   PubMed Web of Science ®Google Scholar
• Adaimy L , ChoueryE, MegarbaneHet al.: Mutation in WNT10A is associated with an autosomal recessive ectodermal dysplasia: the odonto–onycho–dermal dysplasia. Am. J. Hum. Genet.81, 821–828(2007).
   PubMed Web of Science ®Google Scholar
• Balemans W , Van Hul W: The genetics of low-density lipoprotein receptor-related protein 5 in bone: a story of extremes. Endocrinology148(6), 2622–2629(2007).
   PubMed Web of Science ®Google Scholar
• Balemans W , Van Hul W: Human genetics of SOST. J. Musculoskelet. Neuronal. Interact.6, 355–356(2006).
   PubMedGoogle Scholar
• Grundberg E , LauEM, LorentzsonMet al.: Large-scale association study between two coding LRP5 gene polymorphisms and bone phenotypes and fractures in men. Osteoporos. Int.19, 829–837(2008).
   PubMed Web of Science ®Google Scholar
• Kiel DP , FerrariSL, CupplesLAet al.: Genetic variation at the low-density lipoprotein receptor-related protein 5 (LRP5) locus modulates Wnt signaling and the relationship of physical activity with bone mineral density in men. Bone40, 587–596(2007).
   PubMed Web of Science ®Google Scholar
• Urano T , ShirakiM, EzuraYet al.: Association of a single-nucleotide polymorphism in low-density lipoprotein receptor-related protein 5 gene with bone mineral density. J. Bone Miner. Metab.22, 341–345(2004).
   PubMed Web of Science ®Google Scholar
• Xiong DH , LeiSF, YangFet al.: Low-density lipoprotein receptor-related protein 5 (LRP5) gene polymorphisms are associated with bone mass in both Chinese and whites. J. Bone Miner. Res.22, 385–393(2007).
   PubMed Web of Science ®Google Scholar
• Ferrari S , DeutschS, ChoudhuryUet al.: Polymorphisms in the low-density lipoprotein-related protein 5 (LRP5) gene are associated with variation in vertebral bone mass, vertebral bone size, and stature in whites. Am. J. Human Genet.74, 866–875(2004).
   PubMed Web of Science ®Google Scholar
• van Meurs JB , TrikalinosTA, RalstonSHet al.: Large-scale analysis of association between LRP5 and LRP6 variants and osteoporosis. JAMA299, 1277–1290(2008).
   PubMed Web of Science ®Google Scholar
• Giroux S , ElfassihiL, ColeDE, RousseauF: Replication of associations between LRP5 and ESRRA variants and bone density in premenopausal women.Osteoporos. Int. (2008).
   PubMed Web of Science ®Google Scholar
• Giroux S , ElfassihiL, CardinalG, Laflamme N, Rousseau F: LRP5 coding polymorphisms influence the variation of peak bone mass in a normal population of French–Canadian women. Bone40, 1299–1307(2007).
   PubMed Web of Science ®Google Scholar
• Saarinen A , ValimakiVV, ValimakiMJet al.: The A1330V polymorphism of the low-density lipoprotein receptor-related protein 5 gene (LRP5) associates with low peak bone mass in young healthy men. Bone40, 1006–1012(2007).
   PubMed Web of Science ®Google Scholar
• Koay MA , TobiasJH, LearySD, SteerCD, Vilarino-GuellC, BrownMA: The effect of LRP5 polymorphisms on bone mineral density is apparent in childhood.Calcif. Tissue Int.81, 1–9(2007).
   PubMed Web of Science ®Google Scholar
• Cheung CL , HuangQY, ChanV, KungAW: Association of low-density lipoprotein receptor-related protein 5 (LRP5) promoter SNP with peak bone mineral density in Chinese women.Human Heredity65, 232–239(2008).
   PubMed Web of Science ®Google Scholar
• Koller DL , IchikawaS, JohnsonMLet al.: Contribution of the LRP5 gene to normal variation in peak BMD in women. J. Bone Miner. Res.20, 75–80(2005).
   PubMed Web of Science ®Google Scholar
• Balemans W , FoernzlerD, ParsonsCet al.: Lack of association between the SOST gene and bone mineral density in perimenopausal women: analysis of five polymorphisms. Bone31, 515–519(2002).
   PubMedGoogle Scholar
• Uitterlinden AG , ArpPP, PaeperBWet al.: Polymorphisms in the sclerosteosis/van Buchem disease gene (SOST) region are associated with bone-mineral density in elderly whites. Am. J. Hum. Genet.75, 1032–1045(2004).
   PubMed Web of Science ®Google Scholar
• Fazzalari NL , KuliwabaJS, AtkinsGJ, ForwoodMR, FindlayDM: The ratio of messenger RNA levels of receptor activator nuclear κB ligand to osteoprotegerin correlates with bone remodeling indices in normal human cancellous bone but not in osteoarthritis.J. Bone Miner. Res.16, 1015–1027(2001).
   PubMed Web of Science ®Google Scholar
• Mizuno A , AmizukaN, IrieK, Murakami A, Fujise N, Kanno T: Severe osteoporosis in mice lacking osteoclastogenesis inhibitory factor/osteoprotegerin. Biochem. Biophys. Res. Commun.247, 610–615(1998).
   PubMed Web of Science ®Google Scholar
• Lei SF , JiangH, DengFY, DengHW: Searching for genes underlying susceptibility to osteoporotic fracture: current progress and future prospect.Osteoporos. Int.18, 1157–1175(2007).
   PubMed Web of Science ®Google Scholar
• Arko B , PrezeljJ, KomelR, HudlerP, Marc J: Sequence variations in the osteoprotegerin gene promoter in patients with postmenopausal osteoporosis. J. Clin. Endocrinol. Metab.87, 4080–4084(2002).
   PubMed Web of Science ®Google Scholar
• Browner WS , LuiLY, CummingsSR: Associations of serum osteoprotegerin levels with diabetes, stroke, bone density, fractures, and mortality in elderly women.J. Clin. Endocrinol. Metab.86, 631–637(2001).
   PubMed Web of Science ®Google Scholar
• Choi JY , ShinA, ParkSKet al.: Genetic polymorphisms of OPG, RANK, and ESR1 and bone mineral density in Korean postmenopausal women. Calcif. Tissue Int.77, 152–159(2005).
   PubMed Web of Science ®Google Scholar
• Kim JG , KimJH, KimJYet al.: Association between osteoprotegerin (OPG), receptor activator of nuclear factor-κB (RANK), and RANK ligand (RANKL) gene polymorphisms and circulating OPG, soluble RANKL levels, and bone mineral density in Korean postmenopausal women. Menopause14(5), 913–918(2007).
   PubMed Web of Science ®Google Scholar
• Koh JM , ParkBL, KimDJet al.: Identification of novel RANK polymorphisms and their putative association with low BMD among postmenopausal women. Osteoporos. Int.18(3), 323–331(2007).
   PubMed Web of Science ®Google Scholar
• Hsu YH , NiuT, TerwedowHAet al.: Variation in genes involved in the RANKL/RANK/OPG bone remodeling pathway are associated with bone mineral density at different skeletal sites in men. Hum. Genet.118(5), 568–577(2006).
   PubMed Web of Science ®Google Scholar
• Grant SF , ReidDM, BlakeG, HerdR, FogelmanI, RalstonSH: Reduced bone density and osteoporosis associated with a polymorphic Sp1 binding site in the collagen type I α1 gene.Nat. Genet.14, 203–205(1996).
   PubMed Web of Science ®Google Scholar
• Garcia-Giralt N , EnjuanesA, Bustamante M et al.: In vitro functional assay of alleles and haplotypes of two COL1A1-promoter SNPs. Bone36, 902–908(2005).
   PubMed Web of Science ®Google Scholar
• Mann V , HobsonEE, LiBet al.: A COL1A1 Sp1 binding site polymorphism predisposes to osteoporotic fracture by affecting bone density and quality. J. Clin. Invest.107, 899–907(2001).
   PubMed Web of Science ®Google Scholar
• Mann V , RalstonSH: Meta-analysis of COL1A1 Sp1 polymorphism in relation to bone mineral density and osteoporotic fracture.Bone32, 711–717(2003).
   PubMed Web of Science ®Google Scholar
• Efstathiadou Z , TsatsoulisA, IoannidisJP: Association of collagen Iα 1 Sp1 polymorphism with the risk of prevalent fractures: a meta-analysis.J. Bone Miner. Res.16, 1586–1592(2001).
   PubMed Web of Science ®Google Scholar
• Ralston SH , UitterlindenAG, BrandiMLet al.: Large-scale evidence for the effect of the COLIA1 Sp1 polymorphism on osteoporosis outcomes: the GENOMOS study. PLoS Med.3, E90 (2006).
   PubMed Web of Science ®Google Scholar
• Nieves JW : Osteoporosis: the role of micronutrients.Am. J. Clin. Nutrit.81, 1232S–1239S (2005).
   PubMed Web of Science ®Google Scholar
• Yazdanpanah N , ZillikensMC, Rivadeneira F et al.: Effect of dietary B vitamins on BMD and risk of fracture in elderly men and women: the Rotterdam study. Bone41, 987–994(2007).
   PubMed Web of Science ®Google Scholar
• Riancho JA , ValeroC, ZarrabeitiaMT: MTHFR polymorphism and bone mineral density: meta-analysis of published studies.Calcif. Tissue Int.79, 289–293(2006).
   PubMed Web of Science ®Google Scholar
• Abrahamsen B , JorgensenHL, NielsenTLet al.: MTHFR c.677C>T polymorphism as an independent predictor of peak bone mass in Danish men – results from the Odense Androgen Study. Bone38, 215–219(2006).
   PubMed Web of Science ®Google Scholar
• Li M , LauEM, WooJ: Methylenetetrahydrofolate reductase polymorphism (MTHFR C677T) and bone mineral density in Chinese men and women.Bone35, 1369–1374(2004).
   PubMed Web of Science ®Google Scholar
• Miyao M , MoritaH, HosoiTet al.: Association of methylenetetrahydrofolate reductase (MTHFR) polymorphism with bone mineral density in postmenopausal Japanese women. Calcif. Tissue Int.66, 190–194(2000).
   PubMed Web of Science ®Google Scholar
• Bathum L , von Bornemann-Hjelmorbg J, Christiansen L, Madsen JS, Skytthe A, Christensen K: Evidence for an association of methylene tetrahydrofolate reductase polymorphism C677T and an increased rsik of fractures: results from a population-based Danish study. Osteoporos. Int.15, 659–664(2004).
   PubMed Web of Science ®Google Scholar
• Jorgensen HL , MadsenJS, MadsenBet al.: Association of a common allelic polymorphism (C677T) in the methylene tetrahydrofolate reductase gene with a reduced risk of osteoporotic fractures. A case control study in danish postmenopausal women. Calcif. Tissue Int.71, 386–392(2002).
   PubMed Web of Science ®Google Scholar
• Valero C , AlonsoMA, ZarrabeitiaMT, ViaderoC, HernandezJL, RianchoJA: MTHFR C677T polymorphism and osteoporotic fractures.Horm. Metab. Res.39, 543–547(2007).
   PubMed Web of Science ®Google Scholar
• McLean RR , KarasikD, SelhubJet al.: Association of a common polymorphism in the methylenetetrahydrofolate reductase (MTHFR) gene with bone phenotypes depends on plasma folate status. J. Bone Miner. Res.19, 410–418(2004).
   PubMed Web of Science ®Google Scholar
• Yazdanpanah N , UitterlindenAG, Zillikens MC et al.: Low dietary riboflavin but not folate predicts increased fracture risk in postmenopausal women homozygous for the MTHFR 677 T allele. J. Bone Miner. Res.23, 86–94(2008).
   PubMed Web of Science ®Google Scholar
• Abrahamsen B , MadsenJS, ToftengCLet al.: Are effects of MTHFR (C677T) genotype on BMD confined to women with low folate and riboflavin intake? Analysis of food records from the Danish osteoporosis prevention study. Bone36, 577–583(2005).
   PubMed Web of Science ®Google Scholar
• Xiong DH , ZhaoLJ, XiaoPet al.: Robust and comprehensive analysis of 20 osteoporosis candidate genes by very high-density single-nucleotide polymorphism screen among 405 white nuclear families identified significant association and gene–gene interaction. J. Bone Miner. Res.21, 1678–1695(2006).
   PubMed Web of Science ®Google Scholar
• Sims AM , ShephardN, CarterKet al.: Genetic analyses in a sample of individulas with high or low bone density demonstrates association with multiple Wnt pathway genes. J. Bone Miner. Res.23, 459–506(2008).
   Web of Science ®Google Scholar
• Kiel DP , DemissieS, DupuisJ, LunettaKL, MurabitoJM, KarasikD: Genome-wide association with bone mass and geometry in the Framingham Heart Study.BMC Med. Genet.8(Suppl. 1), S14 (2007).
   PubMed Web of Science ®Google Scholar
• Birney E , StamatoyannopoulosJA, DuttaAet al.: Identification and analysis of functional elements in 1% of the human genome by the ENCODE pilot project. Nature447, 799–816(2007).
   PubMed Web of Science ®Google Scholar
• Richards JB , RivadeneiraF, InouyeMet al.: Bone mineral density, osteoporosis, and osteoporotic fractures: a genome-wide association study. Lancet371, 1505–1512(2008).
   PubMed Web of Science ®Google Scholar
• Styrkarsdottir U , HalldorssonBV, GretarsdottirSet al.: Multiple genetic loci for bone mineral density and fractures. N. Engl. J. Med.358, 2355–2365(2008).
   PubMed Web of Science ®Google Scholar
• Chanock SJ , ManolioT, BoehnkeMet al.: Replicating genotype–phenotype associations. Nature447, 655–660(2007).
   PubMed Web of Science ®Google Scholar
• Manolio TA , RodriguezLL, BrooksLet al.: New models of collaboration in genome-wide association studies: the Genetic Association Information Network. Nat. Genet.39, 1045–1051(2007).
   PubMed Web of Science ®Google Scholar

Website

• International HapMap Project. www.hapmap.org
   Google Scholar